Announcement : World Summit of Antivirals

World Summit of Antivirals

The Mission

Viral diseases represent a real challenge for modern medicine with the recent emergence of new viral threats worldwide including HIV/AIDS, SARS, Ebola and Avian flu. Reliable information regarding products and approaches to face this last frontier of infective diseases remains crucial to assure proper development of new preventive and therapeutic treatments.
 
   
Antiviral InteliStrat Inc. intends to become the leading source of information on antiviral drug and vaccine development and provide its vast expertise in virology to people involved in marketing, benchmarking and decision making in the biotech and the pharmaceutical industry.

The Products

Antiviral InteliStrat has created the most complete, up-to-date Database currently available on antiviral drugs and vaccines. Focused exclusively on viruses, this Database regroups over 2300 Product files containing detailed information on compounds and vaccines related to prevention or treatment of viral diseases worldwide.
 
The company is offering this unique source of information on a subscription basis to the biotech and pharmaceutical industry, along with the academia. Customers can access the Database through flexible subscription options designed to fit their specific needs.

Antiviral Database

  • Dedicated only to antiviral drugs and vaccines, with the most complete set of information currently available to scientists, analysts, and drug development / health specialists;
  • Over 2300 Product files on a single web site;
  • More than 540 sponsors or co-sponsors included;
  • Over 40 potential modes of action covered for drugs;
  • More than 9 different types of vaccines listed;
  • Represents products developed worldwide against all viral families causing human diseases;
  • Includes antiviral drugs and vaccines approved for use on the market or at any stage of development, including several products at preclinical and early research stage;
  • Includes antiviral drugs and vaccines that were dropped from clinical trials or were abandoned at various stages of development;
  • Displays hundreds of chemical structures with formulas and molecular weight;
  • Reports mechanism of action and data on viral resistance in the case of drugs;
  • Shows preclinical data and clinical results in human for several products, along with additional information rarely seen on other sites;
  • Includes patent information for many products

A free sample of Database information and Product files is shown in the Database section

Contact us at info@antiviralintelistrat.com for a FREE TRIAL of the Database.

 

Full Access subscription: now only $995* (Academic subscription available at $250) per year.

  • We are now offering 2 additional months absolutely free when you subscribe for one year as a Full Access member (non applicable to an Academic subscription).
  • A one-year subscription provides access to the database to 3 people (3 "seats") from your organization

 

Viral Family Access subscription: starts at $200 per year (cost of subscription depends on viral family)

Custom Access subscription: you pay only for individual product files ($50 or $100)

 

*all prices in US dollars

 

Check out details and complete price list on  Services page 

 

Other services

As a complement, the company is also offering on a consultation basis its vast expertise and knowledge of the biotechnology and pharmaceutical industry to consumers seeking evaluation of novel approaches in antiviral drug and vaccine development.

  • Advertising on Antiviral InteliStrat web site and Database for sponsors seeking partnership;
  • Evaluation of technologies related to vaccine or antiviral drug development in the biotech and pharmaceutical industries